Hongping Long

Dr. Hongping Long

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 2023 in Phytomedicine
Verified
Journal Article
Closed access
YSYan She
Yan She
LSLe Shao
Le Shao
KJKeyan Jiao
Keyan Jiao
RSRuiting Sun
Ruiting Sun
TLTing Lang
Ting Lang
CDChangqing Deng
Changqing Deng

23 July 2023 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
ZDZhe Deng
Zhe Deng
ZOZhaoguang Ouyang
Zhaoguang Ouyang
SMSi Mei
Si Mei
XZXue Zhang
Xue Zhang
QLQian Li
Qian Li
XTXuefei TIAN
Xuefei TIAN

3 June 2023 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
DHduan jia hao
duan jia hao
ZLZhaoyong Li
Zhaoyong Li
ELEnxu Liu
Enxu Liu
HLHongping Long
Hongping Long
LCLong Chen
Long Chen
SYShao-feng Yang
Shao-feng Yang

2 March 2023 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
GCGuo Chun
Guo Chun
XZXuqing Zhou
Xuqing Zhou
XWXu Wang
Xu Wang
HWHaojie Wang
Haojie Wang
JLJian Liu
Jian Liu
DZDesheng Zhou
Desheng Zhou

22 January 2024 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
KJKeyan Jiao
Keyan Jiao
ZLZili Lai
Zili Lai
QCQiaochu Cheng
Qiaochu Cheng
ZYZhengyu Yang
Zhengyu Yang
WLWenxin Liao
Wenxin Liao
YSYan She
Yan She

1 October 2024 in Drug Design, Development and Therapy
Verified
Journal Article
Open access
PDF file
ZZZiyan Zhong
Ziyan Zhong
JLJian Liu
Jian Liu
YLYan Luo
Yan Luo
MWMei Wu
Mei Wu
FQFeng Qiu
Feng Qiu
PMPan Meng
Pan Meng
Background: Depression, a leading cause of disability worldwide, is characterized by dysfunction of immature neurons, resulting in dysregulated calcium homeostasis and impaired structural plasticity. Jujuboside A (JuA), a biologically active compound derived from Semen Ziziphi Spinosae, has demonstrated anti-anxiety and anti-insomnia properties. Recent studies suggest that JuA may be a promising antidepressant, but its underlying mechanisms remain unclear. Methods: Sprague-Dawley rats were subjected to chronic unpredictable mild stress (CUMS) to induce a depression model. JuA (12.5 mg/kg, 25 mg/kg, 50 mg/kg) was administered orally for 4 weeks. Emotional and cognitive function were assessed. Monoamine neurotransmitter levels were measured using enzyme-linked immunosorbent assay (ELISA). The number of immature neurons and calcium homeostasis were evaluated by immunofluorescence. Western blotting and immunofluorescence were employed to detect the expression of Sonic hedgehog (Shh) signaling proteins. Additionally, lentiviral vector expressing Shh shRNA (LV-Shh-RNAi) were infused intracerebrally to investigate the role of Shh in JuA’s antidepressant effects. Results: JuA significantly ameliorated depressive-like behavior and cognitive dysfunction in CUMS rats, increased monoamine neurotransmitter levels in serum and hippocampal tissue, reduced the number of BrdU/DCX (bromodeoxyuridine/doublecortin)-positive immature neurons, and attenuated calcium ion (Ca2+) concentration and Ca2+/calmodulin-dependent protein kinase II (CaMKII) levels in immature neurons. JuA also markedly elevated synaptic density and prominence complexity, upregulated Shh, Gli family zinc finger 1 and 2 (Gli1/2), synaptophysin (Syn) and postsynaptic density protein-95 (PSD-95) expression in the ventral dentate gyrus (vDG). However, knockdown of Shh in the vDG counteracted JuA’s therapeutic effects. Conclusion: These findings collectively suggest that JuA improves depressive-like behavior in CUMS rats by modulating calcium homeostasis and synaptic structural plasticity in immature neurons through the Shh signaling pathway.